Suchergebnisse - "Servin Rojas, Maximiliano"

PubPharm (20)

1

Surveillance Endoscopy in Pediatric Esophageal Atresia : Toward an Evidence-Based Algorithm

enthalten in: Journal of the American College of Surgeons | 2024

von Yasuda, J. | Kamran, A. | Servin Rojas, M. | +9

2

The impact of surgical-oncologic textbook outcome in patients with stage I to III pancreatic ductal adenocarcinoma : A cross-validation study of two national registries

enthalten in: Surgery | 2024

von Petruch, N. | Servin Rojas, M. | Lillemoe, K. | +14

3

Tumor Size Reduction and Serum Carbohydrate Antigen 19-9 Kinetics After Neoadjuvant FOLFIRINOX in Patients With Pancreatic Ductal Adenocarcinoma

enthalten in: Surgery | 2024

von Servin-Rojas, M. | Fong, Z. | Fernandez-Del Castillo, C. | +7

4

Pancreatic Serous Cystadenoma : A Continuing Diagnostic Challenge

enthalten in: Annals of surgery | 2024

von Assawasirisin, C. | Qadan, M. | Aimprasittichai, S. | +5

5

Liver transplantation in Latin America : reality and challenges

enthalten in: Lancet regional health. Americas | 2023

von Aguirre-Villarreal, D. | Servin-Rojas, M. | Sánchez-Cedillo, A. | +16

6

Feasibility, Safety, and Efficacy of Aggressive Multimodal Management of Elderly Patients with Pancreatic Ductal Adenocarcinoma

enthalten in: Annals of surgery | 2023

von Qiao, G. | Fong, Z. | Bolm, L. | +16

7

Facility type is associated with improved perioperative and oncologic outcomes after minimally invasive surgery for pancreatic cancer

enthalten in: HPB : the official journal of the International Hepato Pancreato Biliary Association | 2023

von Servin-Rojas, M. | Shafique, N. | Sell, N. | +2

8

Identification of high-risk features in mucinous cystic neoplasms of the pancreas

enthalten in: Surgery | 2023

von Servin-Rojas, M. | Fong, Z. | Fernandez-Del Castillo, C. | +7

9

Immunotolerance in liver transplantation : a primer for the clinician

enthalten in: Annals of hepatology | 2023

von Pérez-Escobar, J. | Jimenez, J. | Rodríguez-Aguilar, E. | +6

10

Sofosbuvir plus glecaprevir/pibrentasvir as salvage therapy after liver transplantation in NS5A inhibitor-experienced patients. A case series

enthalten in: Gaceta medica de Mexico | 2023

von García-Juárez, I. | Alonzo-García, C. | Contreras, A. | +4